Bioline Rx reported $57.94M in Current Assets for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Bio Path BPTH:US USD 18.14M 2.43M
Bioline Rx BLRX:US USD 57.94M 13.84M
Bluebird Bio BLUE:US USD 160.44M 7.02M
Idera Pharmaceuticals IDRA:US USD 30.07M 4.48M